申请人:XenoPort, Inc.
公开号:US08344028B2
公开(公告)日:2013-01-01
Gamma-amino-butyric acid derivatives that are GABAB receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are disclosed.
本发明涉及一种
GABAB受体
配体的Gamma-
氨基
丁酸衍
生物,包括这种衍
生物的制药组合物,以及使用这种衍
生物和制药组合物治疗疾病的方法。